Intraoperative Dexmedetomidine and Coronary Artery Bypass Graft Surgery
Status:
RECRUITING
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
This is a prospective randomized clinical trial designed to determine the effect of intraoperative dexmedetomidine administration on renal function after coronary artery bypass graft surgery.